- Home
- KIDS vs RAPP Comparison
KIDS vs RAPP Comparison
Compare KIDS & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIDS
- RAPP
- Stock Information
- Founded
- KIDS 2007
- RAPP 2022
- Country
- KIDS United States
- RAPP United States
- Employees
- KIDS N/A
- RAPP N/A
- Industry
- KIDS Medical/Dental Instruments
- RAPP
- Sector
- KIDS Health Care
- RAPP
- Exchange
- KIDS Nasdaq
- RAPP Nasdaq
- Market Cap
- KIDS 524.3M
- RAPP 439.4M
- IPO Year
- KIDS 2017
- RAPP 2024
- Fundamental
- Price
- KIDS $20.91
- RAPP $31.47
- Analyst Decision
- KIDS Strong Buy
- RAPP Strong Buy
- Analyst Count
- KIDS 7
- RAPP 3
- Target Price
- KIDS $34.14
- RAPP $34.67
- AVG Volume (30 Days)
- KIDS 134.8K
- RAPP 904.6K
- Earning Date
- KIDS 11-05-2025
- RAPP 11-06-2025
- Dividend Yield
- KIDS N/A
- RAPP N/A
- EPS Growth
- KIDS N/A
- RAPP N/A
- EPS
- KIDS N/A
- RAPP N/A
- Revenue
- KIDS $220,733,000.00
- RAPP N/A
- Revenue This Year
- KIDS $19.26
- RAPP N/A
- Revenue Next Year
- KIDS $17.15
- RAPP N/A
- P/E Ratio
- KIDS N/A
- RAPP N/A
- Revenue Growth
- KIDS 26.08
- RAPP N/A
- 52 Week Low
- KIDS $16.59
- RAPP $6.43
- 52 Week High
- KIDS $33.14
- RAPP $42.14
- Technical
- Relative Strength Index (RSI)
- KIDS 52.31
- RAPP 80.96
- Support Level
- KIDS $20.29
- RAPP $14.11
- Resistance Level
- KIDS $21.35
- RAPP $17.99
- Average True Range (ATR)
- KIDS 0.88
- RAPP 2.53
- MACD
- KIDS 0.13
- RAPP 0.94
- Stochastic Oscillator
- KIDS 50.85
- RAPP 61.99
About KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
About RAPP Rapport Therapeutics Inc. Common Stock
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.